Using epitope predictions to evaluate efficacy and population coverage of the Mtb72f vaccine for tuberculosis

BACKGROUND: The Mtb72f subunit vaccine for tuberculosis, currently in clinical trials, is hoped to provide improved protection compared to the current BCG vaccine. It is not clear, however, whether Mtb72f would be equally protective in the different human populations suffering from a high burden of...

Descripción completa

Detalles Bibliográficos
Autores principales: McNamara, Lucy A, He, Yongqun, Yang, Zhenhua
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2862017/
https://www.ncbi.nlm.nih.gov/pubmed/20353587
http://dx.doi.org/10.1186/1471-2172-11-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2862017/
https://www.ncbi.nlm.nih.gov/pubmed/20353587
http://dx.doi.org/10.1186/1471-2172-11-18

Ejemplares similares